Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP

被引:57
|
作者
Mitchell, JH [1 ]
Duthie, SJ [1 ]
Collins, AR [1 ]
机构
[1] Rowett Res Inst, Div Cellular Integr, Bucksburn AB21 9SB, Aberdeen, Scotland
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2000年 / 38卷 / 02期
关键词
D O I
10.1207/S15327914NC382_12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate cancer is one of the most common male cancers in Western countries, yet the incidence of this fatal disease remains low in Asian populations. Environmental factors such as diet play an important role in hormone-dependent cancer etiology, and a high phytoestrogen intake may be one factor contributing to the low prostate cancer mortality in Eastern populations. In this study, we investigated the effects of the phytoestrogens genistein, daidzein, coumestrol, and equol on cell growth and DNA damage (strand breakage) in two human prostate tumor cell lines: androgen receptor positive LNCaP and androgen receptor-negative PC-3. Each compound caused growth inhibition at physiologically relevant concentrations (< 10 muM). Genistein induced DNA damage in both cell lines at < 10 muM. Daidzein inhibited cell growth at 10-100 muM yet had no effect on DNA damage at up to 500 muM. Thus, despite their structural similarities, different phytoestrogens inhibit prostate tumor cell growth by independent mechanisms.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 50 条
  • [1] Comparative intraosseal growth of human prostate cancer cell lines LNCaP and PC-3 in the nude mouse
    Soos, G
    Jones, RF
    Haas, GP
    Wang, CY
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4253 - 4258
  • [2] Tocotrienols are superior to tocopherols at the induction of growth arrest in the human prostate cancer cell lines, PC-3 and LNCaP
    Lee, SA
    Campbell, SE
    Min, Q
    Whaley, SG
    Stone, W
    Krishnan, K
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1878S - 1879S
  • [3] Anticancer mechanism of Sinapic acid in PC-3 and LNCaP human prostate cancer cell lines
    Eroglu, Canan
    Avci, Ebru
    Vural, Hasibe
    Kurar, Ercan
    GENE, 2018, 671 : 127 - 134
  • [4] Modulation of growth and apoptosis response in PC-3 and LNCaP prostate-cancer cell lines by Fas
    Takeuchi, T
    Sasaki, Y
    Ueki, T
    Kaziwara, T
    Moriyama, N
    Kawabe, K
    Kakizoe, T
    INTERNATIONAL JOURNAL OF CANCER, 1996, 67 (05) : 709 - 714
  • [5] DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines
    Adjakly, Mawussi
    Bosviel, Remy
    Rabiau, Nadege
    Boiteux, Jean-Paul
    Bignon, Yves-Jean
    Guy, Laurent
    Bernard-Gallon, Dominique
    EPIGENOMICS, 2011, 3 (06) : 795 - 803
  • [6] The determination of the potential anticancer effects of Coriandrum sativum in PC-3 and LNCaP prostate cancer cell lines
    Elmas, Levent
    Secme, Mucahit
    Mammadov, Ramazan
    Fahrioglu, Umut
    Dodurga, Yavuz
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 3506 - 3513
  • [7] Identification of genes expressed differentially by LNCaP or PC-3 prostate cancer cell lines
    Yang, MH
    Loda, M
    Sytkowski, AJ
    CANCER RESEARCH, 1998, 58 (16) : 3732 - 3735
  • [8] Soybean isoflavone, genistein, induces glutathione peroxidase in human prostate cancer cell lines, LNCaP and PC-3
    Suzuki, K
    Koike, H
    Matsui, H
    Hasumi, M
    Ono, Y
    Ito, K
    Yamamoto, T
    Fukabori, Y
    Kurokawa, K
    Yamanaka, H
    JOURNAL OF UROLOGY, 2002, 167 (04): : 50 - 51
  • [9] Cholesterol Homeostasis in Two Commonly Used Human Prostate Cancer Cell-Lines, LNCaP and PC-3
    Krycer, James Robert
    Kristiana, Ika
    Brown, Andrew John
    PLOS ONE, 2009, 4 (12):
  • [10] Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3
    Suzuki, K
    Koike, H
    Matsui, H
    Ono, Y
    Hasumi, M
    Nakazato, H
    Okugi, H
    Sekine, Y
    Oki, K
    Ito, K
    Yamamoto, T
    Fukabori, Y
    Kurokawa, K
    Yamanaka, H
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (06) : 846 - 852